Literature DB >> 1594376

Lethal toxic encephalopathy due to childhood shigellosis in a developed country.

A Goren1, S Freier, J H Passwell.   

Abstract

Shigellosis results in considerable morbidity in endemic areas, but mortality is rare in developed countries. All pediatric deaths (n = 15) in Israel following shigellosis in the past 10 years were reviewed. The patients' ages ranged from 5 months to 11 years; there were eight boys and seven girls. Three were institutionalized mentally retarded patients, 11 were healthy children. Twelve had definite clinical signs of brain death within 48 hours of onset of disease. Cause of death in all patients was consistent with toxic encephalopathy. No other systemic complication was implicated as the cause of death except for one case consistent with a "Reye-like" syndrome. Shigella species were as follows: 8 flexneri, 4 sonnei, 1 dysenteriae, and 2 were not identified. Case-control study of these patients vs surviving, hospitalized patients with shigellosis showed similar severity of fever, diarrhea, vomiting, and dehydration and similar incidence of convulsions. Headache was a prominent feature of patients who died; 5 of 7 verbal patients complained of this symptom as opposed to 2 of 20 in the control group (P less than .01). There were no significant differences in the hematological and biochemical profile (except for an increased incidence of hyponatremia in the study group), pattern of shigella species, or antibiotic sensitivity. These findings indicate that mortality from shigellosis in a developed country is due primarily to the toxic encephalopathy syndrome.

Entities:  

Mesh:

Year:  1992        PMID: 1594376

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

2.  Encephalopathy associated with enteroinvasive Escherichia coli 0144:NM infection.

Authors:  M Ephros; D Cohen; M Yavzori; N Rotman; B Novic; S Ashkenazi
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae.

Authors:  J Balter-Seri; Y Yuhas; A Weizman; Y Nofech-Mozes; E Kaminsky; S Ashkenazi
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae.

Authors:  Y Yuhas; L Shulman; A Weizman; E Kaminsky; A Vanichkin; S Ashkenazi
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

5.  An adult case with shigellosis-associated encephalopathy.

Authors:  Heleen Joséphine Schuster; Michelle Gompelman; Wim Ang; Albertus Jozef Kooter
Journal:  BMJ Case Rep       Date:  2018-01-18

6.  Risk factors and outcome of Shigella encephalopathy in Bangladeshi children.

Authors:  Farzana Afroze; Tahmeed Ahmed; Monira Sarmin; Abu Smsb Shahid; K M Shahunja; Lubaba Shahrin; Mohammod Jobayer Chisti
Journal:  PLoS Negl Trop Dis       Date:  2017-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.